688065.SH
Cathay Biotech, Inc.
SSE · Basic Materials · Chemicals · CN
CNY 37.43
+1.05%Year over year
Reported trailing growth
- Revenue
- +11.3%
- EBITDA
- —
- EBIT
- +12.7%
- EPS
- -2.5%
- Free cash flow
- —
- Operating cash flow
- -57.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +10.5%
- EBITDA
- -0.9%
- EBIT
- -3.6%
- Net income
- +0.4%
- EPS
- -4.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026